Kam Lawrence
data from 31/12/2019
Capitalization
$ 97.381 M
100.00 %
Performance
$ 0.000
0.00 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2019/12/31 | ADVM | ADVERUM BIOTECHNOLOGIES INC | 47.83% | 46.578 M $ | 4043212 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | RGNX | REGENXBIO INC | 19.59% | 19.078 M $ | 465664 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | SRPT | SAREPTA THERAPEUTICS INC | 14.93% | 14.541 M $ | 112689 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | GNW | GENWORTH FINL INC | 9.48% | 9.228 M $ | 2097335 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | FENC | FENNEC PHARMACEUTICALS INC | 5.56% | 5.417 M $ | 834689 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | SPNT | THIRD PT REINS LTD | 2.45% | 2.390 M $ | 227185 | 2019/12/31 | 0.000 $ | 0.00 % |
| 2019/12/31 | TROX | TRONOX HOLDINGS PLC | 0.15% | 149.000 K $ | 13055 | 2019/12/31 | 0.000 $ | 0.00 % |